Eikon Therapeutics is a biopharmaceutical company utilizing revolutionary technology to discover novel treatments for life-threatening diseases. Their discovery platform, founded by Nobel Prize winners in 2014, enables real-time, molecular-resolution measurements of protein movement in living cells.
